Leading Financial Service Provider in India | Canara Bank Securities Ltd

Alkem Laboratories Ltd.

May 29 BSE 5497.80 (+ 45.55 0.84%)

Volume30697

Prev. Close
5452.25

Open Price
5578.00

Today's Low / High

5475.70 5793.50

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

4716.75 5933.00

May 29 NSE 5498.00(+ 46.50 0.85%)

Volume1404988

Prev. Close
5451.50

Open Price
5578.00

Today's Low / High

5472.00 5789.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

4716.20 5933.50

Market Cap. ( ₹ in Cr. )	65736.84	P/BV	4.70	Book Value ( ₹ )	1,170.87
52 Week High/Low ( ₹ )	5934/4716	FV/ML	2/1	P/E(X)	28.56
Book Closure	20/02/2026	EPS ( ₹ )	192.51	Div Yield (%)	0.00

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1195.50	1195.65	1195.65	1195.65	1195.65

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.91	23.91	23.91	23.91	23.91
Total Share Capital	23.91	23.91	23.91	23.91	23.91

Reserves and Surplus	13796.19	11960.96	10268.61	9021.38	8613.99
Total Reserves and Surplus	13796.19	11960.96	10268.61	9021.38	8613.99
Employees Stock Options	0.00	0.00	19.54	0.00	0.00
Total Shareholders Funds	13820.10	11984.87	10312.06	9045.29	8637.90
Minority Interest	528.83	448.76	402.34	389.71	209.43

NON-CURRENT LIABILITIES
Long Term Borrowings	492.45	310.91	40.00	0.00	9.38
Deferred Tax Liabilities [Net]	15.12	0.00	0.00	0.00	0.00
Other Long Term Liabilities	802.56	643.36	526.09	245.14	74.39
Long Term Provisions	431.21	338.22	299.86	369.36	332.75
Total Non-Current Liabilities	1741.34	1292.49	865.95	614.50	416.52

CURRENT LIABILITIES
Short Term Borrowings	1131.05	751.88	1173.97	1307.15	2570.74
Trade Payables	2244.18	1839.35	1748.12	1165.03	1173.38
Other Current Liabilities	1206.82	1214.64	945.59	862.22	787.62
Short Term Provisions	200.65	159.11	126.87	372.75	273.60
Total Current Liabilities	4782.70	3964.98	3994.55	3707.15	4805.34

Total Capital And Liabilities	20872.97	17691.10	15574.90	13756.65	14069.19

ASSETS
NON-CURRENT ASSETS
Tangible Assets	2838.85	2386.15	2408.63	2203.25	2287.10
Intangible Assets	652.42	43.05	47.41	66.41	211.54
Capital Work-In-Progress	137.91	476.55	148.40	310.27	339.48
Intangible Assets Under Development	0.00	71.52	10.17	12.97	0.00
Fixed Assets	3629.18	2977.27	2614.61	2592.90	2838.12
Goodwill On Consolidation	523.64	423.11	416.74	413.17	403.09
Non-Current Investments	1131.50	943.24	334.80	304.61	231.67
Deferred Tax Assets [Net]	1819.35	1738.25	1514.83	1302.50	1309.26
Long Term Loans And Advances	0.00	0.00	0.00	8.02	8.02
Other Non-Current Assets	1558.78	663.41	282.34	405.75	843.60
Total Non-Current Assets	8662.45	6745.28	5163.32	5026.95	5633.76


CURRENT ASSETS
Current Investments	737.31	902.26	148.99	317.21	139.31
Inventories	3333.22	2922.41	2661.18	2607.53	3005.53
Trade Receivables	2979.11	2466.25	2252.81	2132.18	1884.60
Cash And Cash Equivalents	1732.90	1563.08	1579.35	2616.89	2578.58
Short Term Loans And Advances	6.63	9.04	9.07	6.77	20.25
OtherCurrentAssets	3421.35	3082.78	3760.18	1049.12	807.16
Total Current Assets	12210.52	10945.82	10411.58	8729.70	8435.43

Total Assets	20872.97	17691.10	15574.90	13756.65	14069.19

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	995.22	210.67	410.26	425.90

BONUS DETAILS
Bonus Equity Share Capital	0.00	11.96	11.96	11.96	11.96

NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	710.39	170.40	142.67	0.00
Non-Current Investments Unquoted Book Value	0.00	200.47	164.40	161.94	126.59

CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	827.56	46.92	212.14	0.00
Current Investments Unquoted Book Value	0.00	74.70	102.07	105.06	0.00

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR
FaceValue	2.00
No. of Equity Shares (in Lacs)	1195.50

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.91
Total Share Capital	23.91
Reserves and Surplus	13796.19
Total Reserves and Surplus	13796.19
Employees Stock Options	0.00
Total Shareholders Funds	13820.10
Minority Interest	528.83
NON-CURRENT LIABILITIES
Long Term Borrowings	492.45
Deferred Tax Liabilities [Net]	15.12
Other Long Term Liabilities	802.56
Long Term Provisions	431.21
Total Non-Current Liabilities	1741.34
CURRENT LIABILITIES
Short Term Borrowings	1131.05
Trade Payables	2244.18
Other Current Liabilities	1206.82
Short Term Provisions	200.65
Total Current Liabilities	4782.70
Total Capital And Liabilities	20872.97
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2838.85
Intangible Assets	652.42
Capital Work-In-Progress	137.91
Intangible Assets Under Development	0.00
Fixed Assets	3629.18
Goodwill On Consolidation	523.64
Non-Current Investments	1131.50
Deferred Tax Assets [Net]	1819.35
Long Term Loans And Advances	0.00
Other Non-Current Assets	1558.78
Total Non-Current Assets	8662.45
CURRENT ASSETS
Current Investments	737.31
Inventories	3333.22
Trade Receivables	2979.11
Cash And Cash Equivalents	1732.90
Short Term Loans And Advances	6.63
OtherCurrentAssets	3421.35
Total Current Assets	12210.52
Total Assets	20872.97
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00
BONUS DETAILS
Bonus Equity Share Capital	0.00
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00
Non-Current Investments Unquoted Book Value	0.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00
Current Investments Unquoted Book Value	0.00

Markets

Balance Sheet

BALANCE SHEET

Alkem Laboratories Ltd.